Journey Medical DERM Cash Flow Statement (2020-2026)

NASDAQ DERM
$5.27 +0.10 (+1.93%)
As of: Oct 20, 2026 · 11:14 AM EDT
Reported Financials

Journey Medical Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Journey Medical reported cash from operations of -$1.73M and free cash flow of -$1.73M for the quarter ended Jun 2026, down 84.1% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.52M-4.07M-3.80M-2.32M-1.25M-2.23M-0.31M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.70M0.50M1.02M1.00M1.00M1.23M1.07M1.07M0.81M0.82M0.81M0.81M0.81M0.98M1.07M1.06M1.06M1.07M1.13M0.97M
Amortization of Deferred ChargesAmort. Deferred Charges
0.38M1.92M0.01M0.02M0.02M0.02M0.02M0.28M0.06M0.00M0.06M0.06M0.09M0.09M0.10M0.12M0.12M0.12M0.10M0.10M
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
0.01M2.43M0.77M0.77M1.44M1.44M0.65M0.87M0.56M0.53M1.41M1.67M1.64M1.38M1.32M1.34M1.85M1.78M0.99M1.44M
Deferred Taxes
-3.29M8.27M
Gains from Investment SecuritiesGains Investment
0.00M-0.26M
Asset Writedowns and ImpairmentWritedown
3.14M
Other non-cash itemsOther Non-Cash
9.68M0.30M0.15M0.27M0.28M0.45M0.25M0.55M0.12M-0.03M0.03M0.17M-1.13M-0.29M0.22M-0.42M0.10M-0.02M0.05M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
5.54M-8.51M8.00M-2.48M-0.08M-0.05M-0.47M-10.43M-8.83M7.18M-5.42M0.81M0.88M-0.75M7.99M-2.82M2.42M11.76M-4.76M11.24M
Change in InventoryChange Inventory
-2.70M-1.75M0.23M-0.08M-0.82M-1.07M-0.88M-1.11M-1.14M-0.82M0.37M-0.89M2.10M2.64M-1.94M0.36M-1.03M-2.19M-0.33M-1.14M
Change in Account PayablesChange Payables
23.72M-5.46M4.73M5.79M0.88M2.94M7.09M-11.89M-3.61M-10.02M-2.81M-0.74M0.74M0.71M-1.65M-1.65M-1.20M-2.71M-0.65M-0.15M
Change in Accured ExpensesChange Accured Exp.
-10.52M-2.12M2.93M-6.52M-1.59M1.61M-2.01M5.95M-7.30M4.32M-0.32M-4.06M0.04M1.42M5.59M-0.45M-1.36M6.37M-1.47M5.73M
Change in TaxesChange Taxes
0.01M0.10M-0.10M0.01M0.01M-0.08M-0.02M-0.04M0.06M0.00M0.01M0.00M
Change in Other Operating AssetsOther Assets Change
1.38M0.35M-0.86M-0.58M-0.10M2.36M-0.83M-0.68M-0.87M2.66M-1.01M-0.17M-1.16M1.96M-0.82M0.08M-0.84M1.74M0.09M-0.73M
Change in Other Operating LiabilitiesOther Liabilities Change
0.35M0.72M-0.15M-0.18M-0.31M0.32M-0.06M0.21M0.47M-0.92M-0.02M0.04M0.09M0.14M-0.14M0.42M-0.11M-0.32M-0.01M-0.04M
Other Working Capital ChangesOther WC Changes
-1.02M0.37M0.71M0.40M-0.21M-2.04M0.78M0.89M1.34M-3.59M0.99M0.21M1.25M-1.83M0.67M0.34M0.73M-2.06M-0.10M0.69M
Cash from OperationsCash from Ops.
7.10M-3.21M0.88M-3.30M-7.28M-3.84M-0.96M3.97M18.75M-16.52M-5.02M-5.18M-1.16M2.23M-2.83M-0.94M-2.38M-6.28M2.91M-1.73M
Investing Activities
Capital ExpendituresCapex
20.00M5.00M
Change in Property, Plant and EquipmentChange in PP&E
-20.00M-5.00M
Change in IntangiblesChange Intangibless
1.20M20.00M
Cash from Investing ActivitiesCash from Investing
-1.20M-20.00M-5.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
14.76M5.00M-0.05M5.05M
Long-Term Debt RepaymentsLT Debt Repayment
2.50M2.00M1.00M2.00M11.00M0.63M0.63M
Non-Current Debt
-2.50M12.76M4.00M-2.00M-11.00M-0.05M4.43M-0.63M
Short-Term Debt issuancesST Debt Issuance
28.00M
Short-Term Debt repaymentsST Debt Repayment
0.89M0.81M2.05M27.95M3.00M
Current Debt
-0.89M-0.81M-2.05M0.05M-3.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-2.50M-0.89M11.95M4.00M-4.05M0.05M-3.00M-11.00M-0.05M4.43M-0.63M
Change in Capital Stock
Common Stock IssuedStock Issued
32.54M0.03M0.02M4.59M1.64M0.03M0.38M6.24M4.22M0.17M7.11M5.43M0.22M0.16M
Net Shares Issued and RepurchasedNet Shares Issued
32.54M0.03M0.02M4.59M1.64M0.03M0.38M6.24M4.22M0.17M7.11M5.43M0.22M0.16M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
4.64M
Net Equity Issued and RepurchasedNet Equity Issued
4.64M32.54M0.03M0.02M4.59M1.64M0.03M0.38M6.24M4.22M0.17M7.11M5.43M0.22M0.16M
Other financing activitiesOther financing
-0.46M-1.55M-0.59M0.37M-0.38M
Cash from Financing ActivitiesCash from Financing
11.21M31.80M11.37M0.11M4.03M0.95M0.05M-13.09M-10.98M19.21M1.64M5.03M-0.29M10.62M3.60M0.17M7.04M5.43M0.22M0.16M
Additional items
Change in Cash
9.51M27.39M-7.75M-3.19M-3.25M-2.89M-5.90M-9.12M7.77M2.69M-3.38M-0.15M-1.45M-2.16M0.77M-0.78M4.66M-0.86M3.13M-1.58M
Ending Cash Balance
21.69M49.08M41.33M38.14M34.89M32.00M26.10M16.98M24.75M27.44M24.06M23.91M22.46M20.31M21.07M20.29M24.95M24.09M27.22M25.64M
Free Cash FlowFCF
7.10M-3.21M-19.12M-3.30M-7.28M-3.84M-5.96M3.97M18.75M-16.52M-5.02M-5.18M-1.16M2.23M-2.83M-0.94M-2.38M-6.28M2.91M-1.73M
Net Cash FlowNCF
18.31M27.39M-7.75M-3.19M-3.25M-2.89M-5.90M-9.12M7.77M2.69M-3.38M-0.15M-1.45M12.84M0.77M-0.78M4.66M-0.86M3.13M-1.58M
Interest Paid
0.10M0.28M0.36M0.26M0.54M0.48M0.12M0.27M0.49M0.59M0.67M0.81M0.78M0.81M0.83M0.81M0.78M
Income Taxes PaidTaxes Paid
0.00M0.15M0.01M0.08M0.10M0.00M0.02M

Journey Medical Cash Flow Statement API

Pull Journey Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DERM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY